- 4-Week # shares sold: 2,500
- 12-Week # shares sold: 2,500
- 24-Week # shares sold: 65,741
Medical technology companies are hot, says Rich Newitter, managing director at Leerink.
These four small-cap stocks would be a healthy addition to your portfolio, says David Swank, portfolio manager for the Hood River Small-Cap Growth Fund.
Zimmer's return to growth is fueling acquisition thoughts by analysts. There are a number of possibilities.